Galmed Pharmaceuticals Ownership 2024 | Who Owns Galmed Pharmaceuticals Now?


OverviewForecastFinancialsChart

Institutional Ownership

1838.53%

Insider Ownership

3.66%

Retail Ownership

-1742.19%

Institutional Holders

20.00

Galmed Pharmaceuticals Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
WELLS FARGO & COMPANY/MN----3,050-100.00%-Jun 30, 2023
MORGAN STANLEY----204,245-100.00%-Jun 30, 2023
BVF INC/IL----1,347,755-100.00%-Jun 30, 2023
RAYMOND JAMES & ASSOCIATES----138,040-100.00%-Jun 30, 2023
BOURGEON CAPITAL MANAGEMENT LLC----500-100.00%-Jun 30, 2023
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO----10-100.00%-Jun 30, 2023
BNP PARIBAS ARBITRAGE, SNC----13,716-100.00%-Jun 30, 2023
GEODE CAPITAL MANAGEMENT, LLC----27,177-100.00%-Jun 30, 2023
MILLENNIUM MANAGEMENT LLC----131,628-100.00%-Jun 30, 2023
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.----28,500-100.00%-Jun 30, 2023
CITADEL ADVISORS LLC----40,844-100.00%-Jun 30, 2023
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.----27,900-100.00%-Jun 30, 2023
VIRTU FINANCIAL LLC----31,633-100.00%-Jun 30, 2023
ALLWORTH FINANCIAL LP----250-100.00%-Jun 30, 2023
JANE STREET GROUP, LLC----13,189-100.00%-Jun 30, 2023
UBS GROUP AG----4,307-100.00%-Jun 30, 2023
BELPOINTE ASSET MANAGEMENT LLC----14,050-100.00%-Jun 30, 2023
TSFG, LLC----3,000-100.00%-Jun 30, 2023
ZRC WEALTH MANAGEMENT, LLC----100-100.00%-Jun 30, 2023

Galmed Pharmaceuticals's largest institutional shareholder is WELLS FARGO & COMPANY/MN, holding 0.00% of the company's total share outstanding, currently valued at -. The top 10 institutional shareholders own together 0.00% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
WELLS FARGO & COMPANY/MN----3,050-100.00%-Jun 30, 2023
MORGAN STANLEY----204,245-100.00%-Jun 30, 2023
BVF INC/IL----1,347,755-100.00%-Jun 30, 2023
RAYMOND JAMES & ASSOCIATES----138,040-100.00%-Jun 30, 2023
BOURGEON CAPITAL MANAGEMENT LLC----500-100.00%-Jun 30, 2023
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO----10-100.00%-Jun 30, 2023
BNP PARIBAS ARBITRAGE, SNC----13,716-100.00%-Jun 30, 2023
GEODE CAPITAL MANAGEMENT, LLC----27,177-100.00%-Jun 30, 2023
MILLENNIUM MANAGEMENT LLC----131,628-100.00%-Jun 30, 2023
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.----28,500-100.00%-Jun 30, 2023
CITADEL ADVISORS LLC----40,844-100.00%-Jun 30, 2023
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.----27,900-100.00%-Jun 30, 2023
VIRTU FINANCIAL LLC----31,633-100.00%-Jun 30, 2023
ALLWORTH FINANCIAL LP----250-100.00%-Jun 30, 2023
JANE STREET GROUP, LLC----13,189-100.00%-Jun 30, 2023
UBS GROUP AG----4,307-100.00%-Jun 30, 2023
BELPOINTE ASSET MANAGEMENT LLC----14,050-100.00%-Jun 30, 2023
TSFG, LLC----3,000-100.00%-Jun 30, 2023
ZRC WEALTH MANAGEMENT, LLC----100-100.00%-Jun 30, 2023

The largest Galmed Pharmaceuticals shareholder by % of total assets is WELLS FARGO & COMPANY/MN. The company owns 0.00 shares of Galmed Pharmaceuticals (GLMD), representing 0.00% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO----10-100.00%-Jun 30, 2023
ZRC WEALTH MANAGEMENT, LLC----100-100.00%-Jun 30, 2023
ALLWORTH FINANCIAL LP----250-100.00%-Jun 30, 2023
BOURGEON CAPITAL MANAGEMENT LLC----500-100.00%-Jun 30, 2023
TSFG, LLC----3,000-100.00%-Jun 30, 2023
WELLS FARGO & COMPANY/MN----3,050-100.00%-Jun 30, 2023
UBS GROUP AG----4,307-100.00%-Jun 30, 2023
JANE STREET GROUP, LLC----13,189-100.00%-Jun 30, 2023
BNP PARIBAS ARBITRAGE, SNC----13,716-100.00%-Jun 30, 2023
BELPOINTE ASSET MANAGEMENT LLC----14,050-100.00%-Jun 30, 2023
GEODE CAPITAL MANAGEMENT, LLC----27,177-100.00%-Jun 30, 2023
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.----27,900-100.00%-Jun 30, 2023
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.----28,500-100.00%-Jun 30, 2023
VIRTU FINANCIAL LLC----31,633-100.00%-Jun 30, 2023
CITADEL ADVISORS LLC----40,844-100.00%-Jun 30, 2023
MILLENNIUM MANAGEMENT LLC----131,628-100.00%-Jun 30, 2023
RAYMOND JAMES & ASSOCIATES----138,040-100.00%-Jun 30, 2023
MORGAN STANLEY----204,245-100.00%-Jun 30, 2023
BVF INC/IL----1,347,755-100.00%-Jun 30, 2023

As of Jun 30 2023, Galmed Pharmaceuticals's largest institutional buyer is NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO. The company purchased -10.00 stocks of GLMD, valued at -.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BVF INC/IL----1,347,755-100.00%-Jun 30, 2023
MORGAN STANLEY----204,245-100.00%-Jun 30, 2023
RAYMOND JAMES & ASSOCIATES----138,040-100.00%-Jun 30, 2023
MILLENNIUM MANAGEMENT LLC----131,628-100.00%-Jun 30, 2023
CITADEL ADVISORS LLC----40,844-100.00%-Jun 30, 2023
VIRTU FINANCIAL LLC----31,633-100.00%-Jun 30, 2023
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.----28,500-100.00%-Jun 30, 2023
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.----27,900-100.00%-Jun 30, 2023
GEODE CAPITAL MANAGEMENT, LLC----27,177-100.00%-Jun 30, 2023
BELPOINTE ASSET MANAGEMENT LLC----14,050-100.00%-Jun 30, 2023
BNP PARIBAS ARBITRAGE, SNC----13,716-100.00%-Jun 30, 2023
JANE STREET GROUP, LLC----13,189-100.00%-Jun 30, 2023
UBS GROUP AG----4,307-100.00%-Jun 30, 2023
WELLS FARGO & COMPANY/MN----3,050-100.00%-Jun 30, 2023
TSFG, LLC----3,000-100.00%-Jun 30, 2023
BOURGEON CAPITAL MANAGEMENT LLC----500-100.00%-Jun 30, 2023
ALLWORTH FINANCIAL LP----250-100.00%-Jun 30, 2023
ZRC WEALTH MANAGEMENT, LLC----100-100.00%-Jun 30, 2023
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO----10-100.00%-Jun 30, 2023

As of Jun 30 2023, Galmed Pharmaceuticals's biggest institutional seller is BVF INC/IL. The company sold -1.35M shares of GLMD, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BVF INC/IL----1,347,755-100.00%-Jun 30, 2023
MORGAN STANLEY----204,245-100.00%-Jun 30, 2023
RAYMOND JAMES & ASSOCIATES----138,040-100.00%-Jun 30, 2023
MILLENNIUM MANAGEMENT LLC----131,628-100.00%-Jun 30, 2023
CITADEL ADVISORS LLC----40,844-100.00%-Jun 30, 2023
VIRTU FINANCIAL LLC----31,633-100.00%-Jun 30, 2023
CAMBRIDGE INVESTMENT RESEARCH ADVISORS, INC.----28,500-100.00%-Jun 30, 2023
RAYMOND JAMES FINANCIAL SERVICES ADVISORS, INC.----27,900-100.00%-Jun 30, 2023
GEODE CAPITAL MANAGEMENT, LLC----27,177-100.00%-Jun 30, 2023
BELPOINTE ASSET MANAGEMENT LLC----14,050-100.00%-Jun 30, 2023
BNP PARIBAS ARBITRAGE, SNC----13,716-100.00%-Jun 30, 2023
JANE STREET GROUP, LLC----13,189-100.00%-Jun 30, 2023
UBS GROUP AG----4,307-100.00%-Jun 30, 2023
WELLS FARGO & COMPANY/MN----3,050-100.00%-Jun 30, 2023
TSFG, LLC----3,000-100.00%-Jun 30, 2023
BOURGEON CAPITAL MANAGEMENT LLC----500-100.00%-Jun 30, 2023
ALLWORTH FINANCIAL LP----250-100.00%-Jun 30, 2023
ZRC WEALTH MANAGEMENT, LLC----100-100.00%-Jun 30, 2023
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO----10-100.00%-Jun 30, 2023

Galmed Pharmaceuticals's largest sold out institutional shareholder by shares sold is BVF INC/IL, sold -1.35M shares, valued at -, as of undefined.

Galmed Pharmaceuticals Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
ETF Managers Trust0.01%72,640--Dec 31, 2023
NORTHERN FUNDS0.00%209--Dec 29, 2023

Galmed Pharmaceuticals's largest mutual fund holder by % of total assets is "ETF Managers Trust", owning 72.64K shares, compromising 0.01% of its total assets.

Galmed Pharmaceuticals Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 232011.11%
31 Dec, 2218-14.29%
30 Sep, 222110.53%
30 Jun, 2219-13.64%
31 Mar, 2222-
31 Dec, 2122-4.35%
30 Sep, 2123-
30 Jun, 2123-17.86%
31 Mar, 212840.00%
31 Dec, 2020-13.04%
30 Sep, 2023-4.17%
30 Jun, 2024-22.58%
31 Mar, 20313.33%
31 Dec, 19307.14%
30 Sep, 1928-9.68%
30 Jun, 1931-6.06%
31 Mar, 1933-21.43%
31 Dec, 184210.53%
30 Sep, 1838-13.64%
30 Jun, 1844120.00%
31 Mar, 18205.26%
31 Dec, 171972.73%
30 Sep, 171110.00%
30 Jun, 171025.00%
31 Mar, 178-33.33%
31 Dec, 1612-29.41%
30 Sep, 1617-5.56%
30 Jun, 1618-
31 Mar, 1618-10.00%
31 Dec, 1520-4.76%
30 Sep, 1521-4.55%
30 Jun, 1522-
31 Mar, 152237.50%
31 Dec, 1416-15.79%
30 Sep, 1419-9.52%
30 Jun, 14215.00%
31 Mar, 1420-

As of 31 Mar 23, 20 institutions are holding Galmed Pharmaceuticals's shares, representing an increase of 11.11% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 232,059,431-14.30%
31 Dec, 222,403,092-6.56%
30 Sep, 222,571,7862.48%
30 Jun, 222,509,581-10.68%
31 Mar, 222,809,617-24.86%
31 Dec, 213,739,038-10.62%
30 Sep, 214,183,339-12.45%
30 Jun, 214,778,208-15.22%
31 Mar, 215,635,779-9.88%
31 Dec, 206,253,692-6.05%
30 Sep, 206,656,415-10.28%
30 Jun, 207,419,1653.72%
31 Mar, 207,152,86621.77%
31 Dec, 195,874,033-6.56%
30 Sep, 196,286,565-18.54%
30 Jun, 197,717,3253.38%
31 Mar, 197,464,795-2.23%
31 Dec, 187,635,4140.30%
30 Sep, 187,612,638-14.32%
30 Jun, 188,885,013233.19%
31 Mar, 182,666,611-2.30%
31 Dec, 172,729,302117.61%
30 Sep, 171,254,22219.32%
30 Jun, 171,051,13214.34%
31 Mar, 17919,3264.97%
31 Dec, 16875,75824.00%
30 Sep, 16706,24028.37%
30 Jun, 16550,148-23.83%
31 Mar, 16722,308-7.27%
31 Dec, 15778,961-84.69%
30 Sep, 155,087,073512.39%
30 Jun, 15830,694-12.42%
31 Mar, 15948,4931.97%
31 Dec, 14930,177-20.04%
30 Sep, 141,163,288-36.08%
30 Jun, 141,820,0528.40%
31 Mar, 141,678,980-

Galmed Pharmaceuticals (GLMD) has 2.06M shares outstanding as of 31 Mar 23, down -14.30% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 231838.53%0.04%
31 Dec, 222145.33%0.04%
30 Sep, 222295.93%0.05%
30 Jun, 222240.40%0.04%
31 Mar, 222508.25%0.02%
31 Dec, 213337.98%0.02%
30 Sep, 213734.62%0.02%
30 Jun, 214265.69%0.02%
31 Mar, 215031.27%0.02%
31 Dec, 205582.91%0.02%
30 Sep, 205942.43%0.01%
30 Jun, 206623.37%0.02%
31 Mar, 206385.63%0.02%
31 Dec, 195243.97%0.02%
30 Sep, 195612.25%0.01%
30 Jun, 196889.55%0.02%
31 Mar, 196664.10%0.01%
31 Dec, 186816.42%0.01%
30 Sep, 186796.09%0.01%
30 Jun, 187931.98%0.14%
31 Mar, 182380.58%0.04%
31 Dec, 172436.55%0.19%
30 Sep, 171119.69%0.13%
30 Jun, 17938.38%0.14%
31 Mar, 17820.72%0.13%
31 Dec, 16781.82%0.20%
30 Sep, 16630.49%0.26%
30 Jun, 16491.14%0.12%
31 Mar, 16644.83%0.13%
31 Dec, 15695.41%0.00%
30 Sep, 154541.42%0.83%
30 Jun, 15741.59%0.10%
31 Mar, 15846.76%0.12%
31 Dec, 14830.40%0.08%
30 Sep, 141038.51%0.04%
30 Jun, 141624.83%0.07%
31 Mar, 141498.89%-

As of 31 Mar 23, Galmed Pharmaceuticals is held by 1838.53% institutional shareholders, representing a 0.04% growth compared to 31 Dec 22.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 23740.00%
31 Dec, 225-37.50%
30 Sep, 228-20.00%
30 Jun, 221066.67%
31 Mar, 226-25.00%
31 Dec, 218-
30 Sep, 21860.00%
30 Jun, 215-61.54%
31 Mar, 211344.44%
31 Dec, 209-
30 Sep, 209-10.00%
30 Jun, 2010-33.33%
31 Mar, 2015-6.25%
31 Dec, 191645.45%
30 Sep, 1911-21.43%
30 Jun, 191416.67%
31 Mar, 1912-42.86%
31 Dec, 18215.00%
30 Sep, 1820-44.44%
30 Jun, 1836227.27%
31 Mar, 1811-26.67%
31 Dec, 1715114.29%
30 Sep, 17740.00%
30 Jun, 17566.67%
31 Mar, 173-40.00%
31 Dec, 165-44.44%
30 Sep, 16928.57%
30 Jun, 16716.67%
31 Mar, 166-
31 Dec, 156-45.45%
30 Sep, 151122.22%
30 Jun, 159-25.00%
31 Mar, 151220.00%
31 Dec, 1410-
30 Sep, 1410-
30 Jun, 1410-50.00%
31 Mar, 1420-

7 institutional shareholders have increased their position in GLMD stock as of 31 Mar 23 compared to 5 in the previous quarter (a 40.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 234-60.00%
31 Dec, 221066.67%
30 Sep, 226200.00%
30 Jun, 222-50.00%
31 Mar, 224-20.00%
31 Dec, 215-
30 Sep, 215-37.50%
30 Jun, 218100.00%
31 Mar, 214-20.00%
31 Dec, 20525.00%
30 Sep, 20433.33%
30 Jun, 203-50.00%
31 Mar, 20620.00%
31 Dec, 195-16.67%
30 Sep, 196-33.33%
30 Jun, 199-18.18%
31 Mar, 1911-
31 Dec, 181157.14%
30 Sep, 187133.33%
30 Jun, 183-25.00%
31 Mar, 184-
31 Dec, 17--100.00%
30 Sep, 171-
30 Jun, 17--
31 Mar, 17--100.00%
31 Dec, 162100.00%
30 Sep, 161-50.00%
30 Jun, 162-50.00%
31 Mar, 164-20.00%
31 Dec, 155400.00%
30 Sep, 151-83.33%
30 Jun, 15650.00%
31 Mar, 154300.00%
31 Dec, 141-80.00%
30 Sep, 14566.67%
30 Jun, 143-
31 Mar, 14--

4 institutional shareholders have reduced their position in GLMD stock as of 31 Mar 23 compared to 10 in the previous quarter (a -60.00% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 232011.11%2,059,431-14.30%1838.53%0.04%740.00%4-60.00%
31 Dec, 2218-14.29%2,403,092-6.56%2145.33%0.04%5-37.50%1066.67%
30 Sep, 222110.53%2,571,7862.48%2295.93%0.05%8-20.00%6200.00%
30 Jun, 2219-13.64%2,509,581-10.68%2240.40%0.04%1066.67%2-50.00%
31 Mar, 2222-2,809,617-24.86%2508.25%0.02%6-25.00%4-20.00%
31 Dec, 2122-4.35%3,739,038-10.62%3337.98%0.02%8-5-
30 Sep, 2123-4,183,339-12.45%3734.62%0.02%860.00%5-37.50%
30 Jun, 2123-17.86%4,778,208-15.22%4265.69%0.02%5-61.54%8100.00%
31 Mar, 212840.00%5,635,779-9.88%5031.27%0.02%1344.44%4-20.00%
31 Dec, 2020-13.04%6,253,692-6.05%5582.91%0.02%9-525.00%
30 Sep, 2023-4.17%6,656,415-10.28%5942.43%0.01%9-10.00%433.33%
30 Jun, 2024-22.58%7,419,1653.72%6623.37%0.02%10-33.33%3-50.00%
31 Mar, 20313.33%7,152,86621.77%6385.63%0.02%15-6.25%620.00%
31 Dec, 19307.14%5,874,033-6.56%5243.97%0.02%1645.45%5-16.67%
30 Sep, 1928-9.68%6,286,565-18.54%5612.25%0.01%11-21.43%6-33.33%
30 Jun, 1931-6.06%7,717,3253.38%6889.55%0.02%1416.67%9-18.18%
31 Mar, 1933-21.43%7,464,795-2.23%6664.10%0.01%12-42.86%11-
31 Dec, 184210.53%7,635,4140.30%6816.42%0.01%215.00%1157.14%
30 Sep, 1838-13.64%7,612,638-14.32%6796.09%0.01%20-44.44%7133.33%
30 Jun, 1844120.00%8,885,013233.19%7931.98%0.14%36227.27%3-25.00%
31 Mar, 18205.26%2,666,611-2.30%2380.58%0.04%11-26.67%4-
31 Dec, 171972.73%2,729,302117.61%2436.55%0.19%15114.29%--100.00%
30 Sep, 171110.00%1,254,22219.32%1119.69%0.13%740.00%1-
30 Jun, 171025.00%1,051,13214.34%938.38%0.14%566.67%--
31 Mar, 178-33.33%919,3264.97%820.72%0.13%3-40.00%--100.00%
31 Dec, 1612-29.41%875,75824.00%781.82%0.20%5-44.44%2100.00%
30 Sep, 1617-5.56%706,24028.37%630.49%0.26%928.57%1-50.00%
30 Jun, 1618-550,148-23.83%491.14%0.12%716.67%2-50.00%
31 Mar, 1618-10.00%722,308-7.27%644.83%0.13%6-4-20.00%
31 Dec, 1520-4.76%778,961-84.69%695.41%0.00%6-45.45%5400.00%
30 Sep, 1521-4.55%5,087,073512.39%4541.42%0.83%1122.22%1-83.33%
30 Jun, 1522-830,694-12.42%741.59%0.10%9-25.00%650.00%
31 Mar, 152237.50%948,4931.97%846.76%0.12%1220.00%4300.00%
31 Dec, 1416-15.79%930,177-20.04%830.40%0.08%10-1-80.00%
30 Sep, 1419-9.52%1,163,288-36.08%1038.51%0.04%10-566.67%
30 Jun, 14215.00%1,820,0528.40%1624.83%0.07%10-50.00%3-
31 Mar, 1420-1,678,980-1498.89%-20---

Galmed Pharmaceuticals Peer Ownership


TickerCompany
ADVMAdverum Biotechnologies, Inc.
MREOMereo BioPharma Group plc
AKBAAkebia Therapeutics, Inc.
ABEOAbeona Therapeutics Inc.
ADAPAdaptimmune Therapeutics plc
MBIOMustang Bio, Inc.
FBIOFortress Biotech, Inc.
APTOAptose Biosciences Inc.
PDSBPDS Biotechnology Corporation
AFMDAffimed N.V.
KODKodiak Sciences Inc.
ACHLAchilles Therapeutics plc
LPTXLeap Therapeutics, Inc.
PIRSPieris Pharmaceuticals, Inc.

GLMD Ownership FAQ


Galmed Pharmaceuticals is owned by institutional shareholders (1838.53%), insiders (3.66%), and public (-1742.19%). The largest institutional shareholder of Galmed Pharmaceuticals is WELLS FARGO & COMPANY/MN (0% of total shares) and the top mutual fund owner is ETF Managers Trust (0.01% of total shares).

Galmed Pharmaceuticals's major institutional shareholders are WELLS FARGO & COMPANY/MN, MORGAN STANLEY, BVF INC/IL, RAYMOND JAMES & ASSOCIATES, and BOURGEON CAPITAL MANAGEMENT LLC. The top five shareholders own together 0% of the company's share outstanding.

As of Mar 2023, there are 20 institutional shareholders of Galmed Pharmaceuticals.

WELLS FARGO & COMPANY/MN owns 0 shares of Galmed Pharmaceuticals, representing 0% of the company's total shares outstanding, valued at $0 (as of Jun 2023).

As of Jun 2023, MORGAN STANLEY holds 0 shares of Galmed Pharmaceuticals (GLMD), compromising 0% of the company, valued at $0.

BVF INC/IL is the third largest holder of Galmed Pharmaceuticals. The company owns 0 of the company's shares outstanding (worth $0).